azd5847
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2009 (NCT01037725)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- azd2563
- azd 2563
- azd5847
- azd5847
- azd5847
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01516203 | Phase 2 | Dec 1, 2012 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT01116258 | Phase 1 | Apr 1, 2010 | AstraZeneca, IQVIA |
| NCT01037725 | Phase 1 | Dec 1, 2009 | AstraZeneca, IQVIA |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| AstraZeneca | For profit | 2 | 2 | 1 | 2009 |
| IQVIA | For profit | 2 | 0 | 1 | 2009 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 1 | 1 | 2012 |
3 organizations
Page 1 / 1